DE69231705D1 - Gag-Env Fusion-Antigen aus HIV - Google Patents
Gag-Env Fusion-Antigen aus HIVInfo
- Publication number
- DE69231705D1 DE69231705D1 DE69231705T DE69231705T DE69231705D1 DE 69231705 D1 DE69231705 D1 DE 69231705D1 DE 69231705 T DE69231705 T DE 69231705T DE 69231705 T DE69231705 T DE 69231705T DE 69231705 D1 DE69231705 D1 DE 69231705D1
- Authority
- DE
- Germany
- Prior art keywords
- gag
- env
- hiv antigen
- hiv
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000427 antigen Substances 0.000 title abstract 6
- 102000036639 antigens Human genes 0.000 title abstract 6
- 108091007433 antigens Proteins 0.000 title abstract 6
- 230000004927 fusion Effects 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 101710177291 Gag polyprotein Proteins 0.000 abstract 1
- 101710125418 Major capsid protein Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108700004026 gag Genes Proteins 0.000 abstract 1
- 101150098622 gag gene Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17027092 | 1992-06-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69231705D1 true DE69231705D1 (de) | 2001-04-05 |
DE69231705T2 DE69231705T2 (de) | 2001-10-18 |
Family
ID=15901829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69231705T Expired - Fee Related DE69231705T2 (de) | 1992-06-04 | 1992-12-02 | Gag-Env Fusion-Antigen aus HIV |
Country Status (8)
Country | Link |
---|---|
US (2) | US5576421A (de) |
EP (1) | EP0572737B1 (de) |
KR (1) | KR0143977B1 (de) |
CN (1) | CN1079509A (de) |
AT (1) | ATE199394T1 (de) |
BR (1) | BR9204851A (de) |
CA (1) | CA2084386C (de) |
DE (1) | DE69231705T2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995016040A2 (en) * | 1993-12-10 | 1995-06-15 | The Canadian Red Cross Society | Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form |
DE4411718A1 (de) * | 1994-04-05 | 1995-10-12 | Gsf Forschungszentrum Umwelt | RFB-Retrovirusgenom |
US6525173B1 (en) * | 1997-01-02 | 2003-02-25 | Universidade Federal De Minas Gerais | Process for expression and production of recombinant protein hybrid protein (p24/p17) derived from human immunodeficiency viruses (HIV-1) |
WO1998043669A1 (en) * | 1997-04-03 | 1998-10-08 | Thomas Jefferson University | Chimeric viral proteins |
ES2341429T3 (es) * | 1999-12-23 | 2010-06-21 | Medical Research Council | Mejoras en las respuestas inmunitarias al vih o relacionadas con las mismas. |
WO2003004657A1 (en) * | 2001-07-05 | 2003-01-16 | Chiron Corporation | Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
US20050112139A1 (en) * | 2003-10-23 | 2005-05-26 | Nmk Research, Llc | Immunogenic composition and method of developing a vaccine based on factor H binding sites |
FR2874612A1 (fr) * | 2004-08-27 | 2006-03-03 | Commissariat Energie Atomique | Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applications |
EP2309269B1 (de) * | 2004-09-08 | 2016-10-26 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Zusammensetzungen und verfahren zur detektion von hiv-1/hiv-2 infektion |
KR101138930B1 (ko) * | 2007-02-16 | 2012-04-25 | (주) 에빅스젠 | Hⅰv nc 단백질을 포함하는 aⅰds 예방 및 치료용조성물 |
CN101475642B (zh) * | 2008-11-07 | 2013-06-05 | 深圳市菲鹏生物股份有限公司 | 一种艾滋病毒重组抗原及其融合蛋白 |
KR102079761B1 (ko) * | 2018-05-14 | 2020-02-20 | 서울대학교산학협력단 | pMyong2 벡터 시스템을 이용하여 HIV-1 p24를 발현하는 재조합 BCG 및 이의 HIV-1 백신으로의 이용 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0227169B1 (de) * | 1985-12-17 | 1993-03-17 | Akzo N.V. | Immunochemisches Reagenz |
US4925784A (en) * | 1986-04-04 | 1990-05-15 | Hoffmann-La Roche Inc. | Expression and purification of an HTLV-III gag/env gene protein |
IE63455B1 (en) * | 1987-09-04 | 1995-04-19 | Int Murex Tech Corp | Immunoassay and biological constructs for use therein |
JPH01179687A (ja) * | 1987-12-30 | 1989-07-17 | Chemo Sero Therapeut Res Inst | Hiv融合蛋白質 |
IL90048A0 (en) * | 1988-04-25 | 1989-12-15 | Merck & Co Inc | Recombinant gag precursor of hiv,its preparation and its use as aids vaccine |
DE68917520T2 (de) * | 1988-05-06 | 1995-01-05 | Ferropas Ag | Verfahren und Systeme zur Herstellung von HIV-Antigenen. |
CA2003383A1 (en) * | 1988-11-23 | 1990-05-23 | Sushil G. Devare | Synthetic dna derived recombinant hiv antigens |
CA2016897A1 (en) | 1989-05-17 | 1990-11-17 | John W. Wills | Retrovirus-mediated secretion of recombinant products |
EP0449116B2 (de) * | 1990-03-21 | 2004-08-25 | Geneart GmbH | Für abgeänderte retrovirale GAG-Polypeptide kodierende DNA-Sequenzen und diese enthaltende Impfstoffe oder Aggregate davon |
-
1992
- 1992-12-02 AT AT92311006T patent/ATE199394T1/de not_active IP Right Cessation
- 1992-12-02 DE DE69231705T patent/DE69231705T2/de not_active Expired - Fee Related
- 1992-12-02 CA CA002084386A patent/CA2084386C/en not_active Expired - Fee Related
- 1992-12-02 EP EP92311006A patent/EP0572737B1/de not_active Expired - Lifetime
- 1992-12-04 CN CN92115396A patent/CN1079509A/zh active Pending
- 1992-12-04 KR KR1019920023362A patent/KR0143977B1/ko not_active IP Right Cessation
- 1992-12-04 BR BR9204851A patent/BR9204851A/pt not_active Application Discontinuation
-
1995
- 1995-01-18 US US08/375,510 patent/US5576421A/en not_active Expired - Fee Related
- 1995-06-07 US US08/487,657 patent/US5834267A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2084386A1 (en) | 1993-12-05 |
EP0572737A2 (de) | 1993-12-08 |
EP0572737A3 (de) | 1994-11-23 |
US5576421A (en) | 1996-11-19 |
BR9204851A (pt) | 1994-06-07 |
CN1079509A (zh) | 1993-12-15 |
KR0143977B1 (ko) | 1998-07-15 |
DE69231705T2 (de) | 2001-10-18 |
US5834267A (en) | 1998-11-10 |
ATE199394T1 (de) | 2001-03-15 |
CA2084386C (en) | 2001-02-20 |
EP0572737B1 (de) | 2001-02-28 |
KR940000117A (ko) | 1994-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU591054B2 (en) | Pre-S gene coded peptide hepatitis B immunogens, vaccines and diagnostics | |
DE69231705T2 (de) | Gag-Env Fusion-Antigen aus HIV | |
DK1278534T3 (da) | Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1 | |
EP0298633A2 (de) | Synthetische Polypeptide | |
AU630861B2 (en) | Recombinant hiv-2 polypeptides | |
RU96108781A (ru) | Пептиды, создающие нейтрализующие антитела к генетически дифергентным штаммам вич-1 | |
KR920002629A (ko) | B형 간염 코어 항원의 아미노산 잔기 서열 | |
PT1417222E (pt) | Polipéptidos isolados baseados no epítopo neutralizante da proteína p17 de vih, úteis como vacinas, e anticorpos antip17 neutralizantes que reconhecem especificamente o referido polipéptido neutralizante | |
WO1997039029A3 (en) | An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof | |
AU6393990A (en) | Hiv related peptides | |
TH13136A (th) | แอนติเจนของ hiv | |
TH13136EX (th) | แอนติเจนของ hiv | |
DK362088A (da) | Fusionsproteiner og fusionsproteinpartikler | |
CA2085084A1 (en) | Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a t-cell stimulatory epitope | |
GR1000021B (el) | Αντιπροσωπευτικο προιον ανοσιογενους ανασυνδυαζομενης ζυμης & μεθοδος καθαρισμου της. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |